Industry Reports

Net sales rise to 14.8 billion euros (currency-adjusted: +4.1 per cent; +11.1 per cent in euro terms) Operating income improves markedly to 2.3 billion euros Key strategic course set for future sustainable business development ...

Teva Pharmaceutical Industries Ltd. announced that it will release its first quarter 2016 financial results on Monday, May 9, 2016 at 7:00 a.m. ET. World pharma today/Industry Reports /- Teva will host a conference call and...

Teva Pharmaceutical Industries Ltd  announced that it will release its first quarter 2016 financial results on Monday, May 9, 2016 at 7:00 a.m. ET. Teva will host a conference call and live webcast on the same...

Eli Lilly and Company announced it will host a meeting for the investment community, including institutional investors, sell-side analysts, ratings agency representatives, and financial and business media. World pharma today/Industry reports/- The meeting will take place...

This program, currently in preclinical development, aims at developing an anti-CD39 mAb; Targeting the adenosine immunosuppressive pathway has potential to promote anti-tumor immune responses across a wide range of tumors; Anti-CD39 broadens Innate Pharma’s portfolio of innovative immuno-oncology...

CTI BioPharma Corp. announced that it has entered into an agreement with institutional investors to purchase 10 million shares of the Company's common stock in a registered direct offering conducted without an underwriter or placement agent for gross proceeds...

Seattle Genetics and Bristol-Myers Squibb (BMS) have entered into a clinical trial collaboration agreement to evaluate the investigational combination of Adcetris and Opdivo in two planned Phase I/II clinical trials. Adcetris (brentuximab vedotin) is Seattle Genetics'...